{"id":187,"date":"2004-02-24T11:15:08","date_gmt":"2004-02-24T15:15:08","guid":{"rendered":"http:\/\/blogs.law.harvard.edu\/rihlib\/2004\/02\/24\/science-and-the-corporation-good-bad-a"},"modified":"2012-05-07T15:33:40","modified_gmt":"2012-05-07T19:33:40","slug":"science-and-the-corporation-good-bad-and-ugly","status":"publish","type":"post","link":"https:\/\/archive.blogs.harvard.edu\/rihlib\/2004\/02\/24\/science-and-the-corporation-good-bad-and-ugly\/","title":{"rendered":"Science and the corporation: good bad and ugly"},"content":{"rendered":"<p><a name='a103'><\/a><\/p>\n<p>the Scientist announces an upcoming workshop titled <a href=\"http:\/\/www.the-scientist.com\/workshops\/intro.html\">From Bench to Boardroom: a Workshop on the Commercialization of Research<\/a>,<br \/>\nincluding sessions on how to start a company.&nbsp; It will take place<br \/>\non April 17 in Washington, DC.&nbsp; However, some may also want to<br \/>\nlook at a recent New York Review article, the <a href=\"http:\/\/www.nybooks.com\/articles\/16954\">Dawn of McScience<\/a>,<br \/>\nby physician and Lancet editor Richard Horton.&nbsp; Reviewing a recent<br \/>\nbook,&nbsp; Science in the Private Interest: Has the Lure of Profits<br \/>\nCorrupted Biomedical Research, by Sheldon Krimsky, he laments several<br \/>\nhigh-profile cases of corporations sponsoring research and influencing<br \/>\nand even surpressing unfavorable results.&nbsp; (On the other hand, as<br \/>\neditor of a journal whose publisher charges close to a hundred grand<br \/>\nfor the Lancet backfiles, maybe he should look closer to home.)<\/p>\n<h5><a href=\"http:\/\/barnesandnoble.bfast.com\/booklink\/click?sourceid=119949&amp;ISBN=074251479X\" class=\"bn-link\" target=\"_blank\" title=\"More about this book from Barnes &amp; Noble\"><br \/>\n<\/a><\/h5>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>the Scientist announces an upcoming workshop titled From Bench to Boardroom: a Workshop on the Commercialization of Research, including sessions on how to start a company.&nbsp; It will take place on April 17 in Washington, DC.&nbsp; However, some may also want to look at a recent New York Review article, the Dawn of McScience, by [&hellip;]<\/p>\n","protected":false},"author":1077,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1379],"tags":[],"class_list":["post-187","post","type-post","status-publish","format-standard","hentry","category-science-news"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/posts\/187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/users\/1077"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/comments?post=187"}],"version-history":[{"count":1,"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/posts\/187\/revisions"}],"predecessor-version":[{"id":796,"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/posts\/187\/revisions\/796"}],"wp:attachment":[{"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/media?parent=187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/categories?post=187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.blogs.harvard.edu\/rihlib\/wp-json\/wp\/v2\/tags?post=187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}